Drug Type Small molecule drug |
Synonyms- |
Target |
Action agonists |
Mechanism GABAA receptor agonists(Gamma-aminobutyric acid A receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC24H34O2 |
InChIKeyQAISRHCMPQROAX-UHFFFAOYSA-N |
CAS Registry2416-95-7 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Cortical Dysplasia-Focal Epilepsy Syndrome | Phase 1 | China | 24 Jun 2022 | |
| Status Epilepticus | Phase 1 | China | 17 Sep 2018 |





